28282614|t|Inhibition of Drp1 protects against senecionine - induced mitochondria -mediated apoptosis in primary hepatocytes and in mice
28282614|a|Pyrrolizidine alkaloids (PAs) are a group of compounds found in various plants and some of them are widely consumed in the world as herbal medicines and food supplements. PAs are potent hepatotoxins that cause irreversible liver injury in animals and humans. However, the mechanisms by which PAs induce liver injury are not clear. In the present study, we determined the hepatotoxicity and molecular mechanisms of senecionine, one of the most common toxic PAs, in primary cultured mouse and human hepatocytes as well as in mice. We found that senecionine administration increased serum alanine aminotransferase levels in mice. H&E and TUNEL staining of liver tissues revealed increased hemorrhage and hepatocyte apoptosis in liver zone 2 areas. Mechanistically, senecionine induced loss of mitochondrial membrane potential, release of mitochondrial cytochrome c as well as mitochondrial JNK translocation and activation prior to the increased DNA fragmentation and caspase-3 activation in primary cultured mouse and human hepatocyte s. SP600125, a specific JNK inhibitor, and ZVAD-fmk, a general caspase inhibitor, alleviated senecionine -induced apoptosis in primary hepatocytes. Interestingly, senecionine also caused marked mitochondria fragmentation in hepatocytes. Pharmacological inhibition of dynamin-related protein1 (Drp1), a protein that is critical to regulate mitochondrial fission, blocked senecionine - induced mitochondrial fragmentation and mitochondrial release of cytochrome c and apoptosis. More importantly, hepatocyte -specific Drp1 knockout mice were resistant to senecionine - induced liver injury due to decreased mitochondrial damage and apoptosis. In conclusion, our results uncovered a novel mechanism of Drp1 -mediated mitochondrial fragmentation in senecionine - induced liver injury. Targeting Drp1 -mediated mitochondrial fragmentation and apoptosis may be a potential avenue to prevent and treat hepatotoxicity induced by PAs.
28282614	0	10	Inhibition	T044	C0021469
28282614	14	18	Drp1	T116,T126	C1957127
28282614	36	47	senecionine	T109,T121	C0074321
28282614	50	57	induced	T169	C0205263
28282614	58	70	mitochondria	T026	C0026237
28282614	81	90	apoptosis	T043	C0162638
28282614	102	113	hepatocytes	T025	C0227525
28282614	121	125	mice	T015	C0026809
28282614	126	149	Pyrrolizidine alkaloids	T109,T123,T131	C0034335
28282614	151	154	PAs	T109,T123,T131	C0034335
28282614	171	180	compounds	T109,T121	C0002062
28282614	198	204	plants	T002	C0032098
28282614	258	274	herbal medicines	T121	C2240391
28282614	279	295	food supplements	T168	C0242295
28282614	297	300	PAs	T109,T123,T131	C0034335
28282614	312	324	hepatotoxins	T131	C0596691
28282614	336	348	irreversible	T037	C0879537
28282614	349	361	liver injury	T037	C0160390
28282614	365	372	animals	T008	C0003062
28282614	377	383	humans	T016	C0086418
28282614	418	421	PAs	T109,T123,T131	C0034335
28282614	422	428	induce	T169	C0205263
28282614	429	441	liver injury	T037	C0160390
28282614	497	511	hepatotoxicity	T037	C0235378
28282614	516	536	molecular mechanisms	T044	C1258062
28282614	540	551	senecionine	T109,T121	C0074321
28282614	576	581	toxic	T131	C0032346
28282614	582	585	PAs	T109,T123,T131	C0034335
28282614	598	606	cultured	T059	C0007585
28282614	607	612	mouse	T015	C0026809
28282614	617	622	human	T016	C0086418
28282614	623	634	hepatocytes	T025	C0227525
28282614	649	653	mice	T015	C0026809
28282614	669	680	senecionine	T109,T121	C0074321
28282614	681	695	administration	T058	C3469597
28282614	696	743	increased serum alanine aminotransferase levels	T033	C0151905
28282614	747	751	mice	T015	C0026809
28282614	753	756	H&E	T059	C0523207
28282614	761	775	TUNEL staining	T063	C1515232
28282614	779	792	liver tissues	T023	C0736268
28282614	793	801	revealed	T080	C0443289
28282614	802	811	increased	T081	C0205217
28282614	812	822	hemorrhage	T046	C0019080
28282614	827	847	hepatocyte apoptosis	T043	C3269241
28282614	851	869	liver zone 2 areas	T029	C0507183
28282614	888	899	senecionine	T109,T121	C0074321
28282614	900	907	induced	T169	C0205263
28282614	908	912	loss	T081	C1517945
28282614	916	948	mitochondrial membrane potential	T043	C1720920
28282614	950	957	release	T169	C1283071
28282614	961	974	mitochondrial	T026	C0026237
28282614	975	987	cytochrome c	T116,T126	C0010749
28282614	999	1012	mitochondrial	T026	C0026237
28282614	1013	1016	JNK	T116,T126	C0380051
28282614	1017	1030	translocation	T043	C0599893
28282614	1059	1068	increased	T081	C0205217
28282614	1069	1086	DNA fragmentation	T044	C0376669
28282614	1091	1100	caspase-3	T116,T126	C0291573
28282614	1101	1111	activation	T045	C0599177
28282614	1123	1131	cultured	T059	C0007585
28282614	1132	1137	mouse	T015	C0026809
28282614	1142	1147	human	T016	C0086418
28282614	1148	1158	hepatocyte	T025	C0227525
28282614	1162	1170	SP600125	T109,T121	C0968383
28282614	1183	1186	JNK	T116,T126	C0380051
28282614	1187	1197	inhibitor,	T121	C0014432
28282614	1202	1210	ZVAD-fmk	T116,T121	C0383779
28282614	1222	1239	caspase inhibitor	T121	C1516312
28282614	1252	1263	senecionine	T109,T121	C0074321
28282614	1273	1282	apoptosis	T043	C0162638
28282614	1294	1305	hepatocytes	T025	C0227525
28282614	1322	1333	senecionine	T109,T121	C0074321
28282614	1353	1379	mitochondria fragmentation	T043	C0230871
28282614	1383	1394	hepatocytes	T025	C0227525
28282614	1396	1411	Pharmacological	T070	C2350477
28282614	1412	1422	inhibition	T044	C0021469
28282614	1426	1450	dynamin-related protein1	T116,T126	C1957127
28282614	1452	1456	Drp1	T116,T126	C1957127
28282614	1461	1468	protein	T116,T123	C0033684
28282614	1489	1519	regulate mitochondrial fission	T043	C2755551
28282614	1521	1528	blocked	T169	C0332206
28282614	1529	1540	senecionine	T109,T121	C0074321
28282614	1543	1550	induced	T169	C0205263
28282614	1551	1578	mitochondrial fragmentation	T043	C0230871
28282614	1583	1596	mitochondrial	T026	C0026237
28282614	1597	1604	release	T169	C1283071
28282614	1608	1620	cytochrome c	T116,T126	C0010749
28282614	1625	1634	apoptosis	T043	C0162638
28282614	1654	1664	hepatocyte	T025	C0227525
28282614	1675	1679	Drp1	T116,T126	C1957127
28282614	1680	1693	knockout mice	T015	C0206745
28282614	1699	1708	resistant	T169	C0332325
28282614	1712	1723	senecionine	T109,T121	C0074321
28282614	1726	1733	induced	T169	C0205263
28282614	1734	1746	liver injury	T037	C0160390
28282614	1754	1763	decreased	T081	C0205216
28282614	1764	1784	mitochondrial damage	T046	C1096176
28282614	1789	1798	apoptosis	T043	C0162638
28282614	1858	1862	Drp1	T116,T126	C1957127
28282614	1873	1900	mitochondrial fragmentation	T043	C0230871
28282614	1904	1915	senecionine	T109,T121	C0074321
28282614	1918	1925	induced	T169	C0205263
28282614	1926	1938	liver injury	T037	C0160390
28282614	1940	1949	Targeting	T044	C1159372
28282614	1950	1954	Drp1	T116,T126	C1957127
28282614	1965	1992	mitochondrial fragmentation	T043	C0230871
28282614	1997	2006	apoptosis	T043	C0162638
28282614	2048	2053	treat	T061	C0087111
28282614	2054	2068	hepatotoxicity	T037	C0235378
28282614	2069	2076	induced	T169	C0205263
28282614	2080	2083	PAs	T109,T123,T131	C0034335